Lipid-lowering market is a trap or a cake-.docVIP

 PAGE \* MERGEFORMAT 9 Lipid-lowering market is a trap or a cake? Three crocodiles, while eye on cholesterol-lowering Some of the lipid-lowering market, China is expected to be as high as billions of dollars. Even more attractive is that, after years of piecemeal lipid-lowering market, still no strong brand presence. According to the common characteristics of the Western market, who took the lead into the consumer mind, blew open the market, it will occupy the first share of the market. For example, Hearts K, Melatonin, Paiduyangyan capsules. So much temptation, who would not slam echocardiography? In 2000-2001, the flagship of China’s three major health care products companies - Jianteshengwu and Panlongyunhai, his wife medicine, while targeting cholesterol-lowering market. Mend his ways - Golden Fort As early as in 2000, Melatonin zenith occasion, Shi Yuzhu has found a ‘second product’, as Melatonin’s ‘stand-in’. It is not everybody is now known as Gold partner, but a cholesterol-lowering health care products - Golden Fortress (also known as ‘Snow nurses’). Jianteshengwu the end of 2000 the product began to plan the preparatory work and do a series of clinical trials testing. Surprisingly, in 2001 Shi Yuzhu a sudden turn, was converted into multi-vitamin. Shi Yuzhu Why drop out lipid-lowering products? The market potential of vitamin greater lipid-lowering product, or see a number of ‘trap’? Have no way out - Knott Participation Shi Yuzhu a loss in the lipid-lowering market, the success of speculation ‘Paiduyangyan’ concept of capital accumulation of thick Panlongyunhai introduced the traditional Chinese medicine ‘37’ mainly materials Knott parameters. Knott Participation in the pilot cities, has invested nearly 10 million of advertising and tragically fell. In early 2002, Knott Participation ingenious ways to dramatically cut prices and tried to price leverage leveraging the market, stimulate consumption, unsuccessfully. In January 2003, Knott Participat